Preclinical evidence for anaplastic lymphoma kinase inhibitors as novel therapeutic treatments for cholangiocarcinoma
间变性淋巴瘤激酶抑制剂作为胆管癌新型治疗方法的临床前证据
期刊:Frontiers in Oncology
影响因子:3.5
doi:10.3389/fonc.2023.1184900
Kyaw Zwar Myint,Mireia Sueca-Comes,Pamela Collier,Brinda Balasubramanian,Simran Venkatraman,John Gordan,Abed M Zaitoun,Abhik Mukherjee,Arvind Arora,Noppadol Larbcharoensub,Chinnawut Suriyonplengsaeng,Kanokpan Wongprasert,Tavan Janvilisri,Dhanny Gomez,Anna M Grabowska,Rutaiwan Tohtong,David O Bates,Kiren Yacqub-Usman